Abstract：
BACKGROUND: We conducted this study to describe the feasibility of high-resolution ultrasound (HRUS) in characterizing a breast implant in patients receiving an implant-based augmentation mammaplasty.
METHODS: The current study was conducted in a total of 612 patients (n =6 12) receiving an implant-based augmentation mammaplasty at other hospitals between August 31, 2017 and August 31, 2020. Of these, 136 patients (n = 136; 272 breasts) receiving reoperation were included in the current study. We compared between the patients\' subjective awareness of a breast implant and its HRUS findings and an agreement between HRUS findings of a breast implant and its findings at reoperation.
RESULTS: The proportion of the patients receiving a silicone gel-filled breast implant was increased from 65.44% (89/136) to 81.61% (111/136) on HRUS. Moreover, HRUS was effective in identifying a manufacturer of the device.
CONCLUSIONS: In conclusion, our results indicate that HRUS is feasible in characterizing a breast implant in patients receiving an implant-based augmentation mammaplasty. But further prospective, large-scale studies are warranted to corroborate our results.
METHODS: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors. www.springer.com/00266 .
METHODS: The current study was conducted in a total of 612 patients (n =6 12) receiving an implant-based augmentation mammaplasty at other hospitals between August 31, 2017 and August 31, 2020. Of these, 136 patients (n = 136; 272 breasts) receiving reoperation were included in the current study. We compared between the patients\' subjective awareness of a breast implant and its HRUS findings and an agreement between HRUS findings of a breast implant and its findings at reoperation.
RESULTS: The proportion of the patients receiving a silicone gel-filled breast implant was increased from 65.44% (89/136) to 81.61% (111/136) on HRUS. Moreover, HRUS was effective in identifying a manufacturer of the device.
CONCLUSIONS: In conclusion, our results indicate that HRUS is feasible in characterizing a breast implant in patients receiving an implant-based augmentation mammaplasty. But further prospective, large-scale studies are warranted to corroborate our results.
METHODS: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors. www.springer.com/00266 .
摘要：
背景：我们进行了这项研究，以描述高分辨率超声（HRUS）在接受基于植入物的隆乳术的患者中表征乳房植入物的可行性。
方法：本研究是在2017年8月31日至2020年8月31日期间在其他医院接受基于植入物的隆乳术的612例患者（n=6.12）中进行的。其中,本研究包括接受再次手术的136例患者（n=136；272例乳房）。我们比较了患者对乳房植入物的主观认识及其HRUS发现，以及乳房植入物的HRUS发现与再次手术时的发现之间的一致性。
结果：在HRUS上，接受硅凝胶填充乳房植入物的患者比例从65.44％（89/136）增加到81.61％（111/136）。此外，HRUS有效地确定了设备的制造商。
结论：结论：我们的结果表明,HRUS在表征接受基于植入物的隆乳术患者的乳房植入物方面是可行的.但进一步的前景，有必要进行大规模的研究来证实我们的结果.
方法：本期刊要求作者为每篇文章分配一定程度的证据。对于这些循证医学评级的完整描述，请参阅目录或在线作者说明。www.springer.com/00266.
方法：本研究是在2017年8月31日至2020年8月31日期间在其他医院接受基于植入物的隆乳术的612例患者（n=6.12）中进行的。其中,本研究包括接受再次手术的136例患者（n=136；272例乳房）。我们比较了患者对乳房植入物的主观认识及其HRUS发现，以及乳房植入物的HRUS发现与再次手术时的发现之间的一致性。
结果：在HRUS上，接受硅凝胶填充乳房植入物的患者比例从65.44％（89/136）增加到81.61％（111/136）。此外，HRUS有效地确定了设备的制造商。
结论：结论：我们的结果表明,HRUS在表征接受基于植入物的隆乳术患者的乳房植入物方面是可行的.但进一步的前景，有必要进行大规模的研究来证实我们的结果.
方法：本期刊要求作者为每篇文章分配一定程度的证据。对于这些循证医学评级的完整描述，请参阅目录或在线作者说明。www.springer.com/00266.
